1. Home
  2. SLXNW
  3. SLXNW News

Latest Biomotion Sciences Warrant (SLXNW) News on November 17, 2024

SLXNW

ACCESSWIRE

3 days ago

Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

SLXNW

ACCESSWIRE

a month ago

Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit

Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies
SLXNW

Business Wire

2 months ago

Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies

Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
SLXNW

Business Wire

2 months ago

Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer

PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
SLXNW

Business Wire

2 months ago

PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers

Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference
SLXNW

GlobeNewswire

2 months ago

Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference

Share on Social Networks: